These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3234491)

  • 1. Activation of a 5-HT3 receptor releases dopamine from rat striatal slice.
    Blandina P; Goldfarb J; Green JP
    Eur J Pharmacol; 1988 Oct; 155(3):349-50. PubMed ID: 3234491
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine.
    Wozniak KM; Pert A; Linnoila M
    Eur J Pharmacol; 1990 Oct; 187(2):287-9. PubMed ID: 2272364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices.
    Zazpe A; Artaiz I; Del Río J
    Br J Pharmacol; 1994 Nov; 113(3):968-72. PubMed ID: 7858893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.
    Blandina P; Goldfarb J; Craddock-Royal B; Green JP
    J Pharmacol Exp Ther; 1989 Dec; 251(3):803-9. PubMed ID: 2600815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal serotonin receptors and dopamine release.
    Balcioglu A; Wurtman RJ
    J Neurochem; 2000 Aug; 75(2):886. PubMed ID: 10899968
    [No Abstract]   [Full Text] [Related]  

  • 6. Endogenous 5-hydroxytryptamine modulates the release of tachykinins and calcitonin gene-related peptide from the rat spinal cord via 5-HT3 receptors.
    Saria A; Javorsky F; Humpel C; Gamse R
    Ann N Y Acad Sci; 1991; 632():464-5. PubMed ID: 1719904
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats.
    Imperato A; Angelucci L
    Neurosci Lett; 1989 Jun; 101(2):214-7. PubMed ID: 2549462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of the antinociceptive effects of intrathecally administered serotonin in the rat by a selective 5-HT3 receptor antagonist.
    Glaum SR; Proudfit HK; Anderson EG
    Neurosci Lett; 1988 Dec; 95(1-3):313-7. PubMed ID: 3226619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine.
    Genova LM; Hyman SE
    Synapse; 1998 Sep; 30(1):71-8. PubMed ID: 9704883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
    Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
    Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT3 receptors modulate spinal nociceptive reflexes.
    Glaum SR; Proudfit HK; Anderson EG
    Brain Res; 1990 Feb; 510(1):12-6. PubMed ID: 2322835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]quaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brain.
    Watling KJ; Aspley S; Swain CJ; Saunders J
    Eur J Pharmacol; 1988 May; 149(3):397-8. PubMed ID: 3409965
    [No Abstract]   [Full Text] [Related]  

  • 13. Ability of 5-HT4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo.
    Steward LJ; Ge J; Stowe RL; Brown DC; Bruton RK; Stokes PR; Barnes NM
    Br J Pharmacol; 1996 Jan; 117(1):55-62. PubMed ID: 8825343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors.
    Ng NK; Lee HS; Wong PT
    J Neurosci Res; 1999 Mar; 55(5):600-7. PubMed ID: 10082082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
    Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of 5-hydroxytryptamine3 receptors in the medial prefrontal cortex: a microiontophoretic study.
    Ashby CR; Edwards E; Harkins K; Wang RY
    Eur J Pharmacol; 1989 Dec; 173(2-3):193-6. PubMed ID: 2560433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M; Sjöholm B; Lappalainen J; Virtanen R
    Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of taurine and dopamine in the striatum.
    Kontro P
    Adv Exp Med Biol; 1987; 217():347-55. PubMed ID: 3434428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local infusion of the selective 5HT-1b agonist CP-93,129 facilitates striatal dopamine release in vivo.
    Galloway MP; Suchowski CS; Keegan MJ; Hjorth S
    Synapse; 1993 Sep; 15(1):90-2. PubMed ID: 8310427
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus.
    Chaput Y; Araneda RC; Andrade R
    Eur J Pharmacol; 1990 Jul; 182(3):441-56. PubMed ID: 2226619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.